​
​

Solid Biosciences Ownership 2024 | Who Owns Solid Biosciences Now?

OverviewForecastRevenueFinancialsChart

Institutional Ownership

0.00%

Insider Ownership

0.85%

Institutional Holders

1.00

Solid Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARALLEL ADVISORS, LLC--7116.67%40Jun 30, 2024

Solid Biosciences's largest institutional shareholder is PARALLEL ADVISORS, LLC, holding 0.00% of the company's total share outstanding, currently valued at $40.00. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARALLEL ADVISORS, LLC--7116.67%40Jun 30, 2024

The largest Solid Biosciences shareholder by % of total assets is PARALLEL ADVISORS, LLC. The company owns 7.00 shares of Solid Biosciences (SLDB), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARALLEL ADVISORS, LLC--7116.67%40Jun 30, 2024

As of Jun 30 2024, Solid Biosciences's largest institutional buyer is PARALLEL ADVISORS, LLC. The company purchased 1.00 stocks of SLDB, valued at $40.00.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARALLEL ADVISORS, LLC--7116.67%40Jun 30, 2024

As of Jun 30 2024, Solid Biosciences's biggest institutional seller is PARALLEL ADVISORS, LLC. The company sold 1.00 shares of SLDB, valued at $40.00.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Solid Biosciences Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
T. Rowe Price New Horizons Fund, Inc.0.39%1,968,876--Mar 31, 2024
BRIDGEWAY FUNDS INC0.12%280,500--Mar 28, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.06%10,839--Mar 28, 2024
VANGUARD VALLEY FORGE FUNDS0.03%14,964--Mar 31, 2024
BRIDGEWAY FUNDS INC0.02%50,071--Mar 28, 2024
QUANTITATIVE MASTER SERIES LLC0.02%103,306--Mar 31, 2024
VANGUARD EXPLORER FUND0.02%193,436--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.02%154,019--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%9,102--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,399--Mar 31, 2024
VANGUARD INDEX FUNDS0.01%3,271,172--Mar 31, 2024
Fidelity Commonwealth Trust II0.01%50,858--Aug 31, 2023
BlackRock Advantage SMID Cap Fund, Inc.0.00%722--Mar 28, 2024
SCHWAB CAPITAL TRUST0.00%126,405--Feb 29, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%12,542--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%550,979--Feb 29, 2024
JNL VARIABLE FUND LLC0.00%14,100--Mar 31, 2020
Principal Exchange-Traded Funds0.00%21,879--Mar 31, 2024
Calvert Variable Products, Inc.0.00%4,720--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%44,513--Mar 31, 2024
Meeder Funds0.00%6,036--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%4,800--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%4,685--Mar 31, 2024
HC CAPITAL TRUST0.00%30,087--Mar 31, 2024
VANGUARD WORLD FUND0.00%191,088--Feb 29, 2024
GPS Funds I0.00%4,034--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%23,367--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%2,205--Feb 29, 2024
Columbia Funds Variable Series Trust II0.00%22,054--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%35,500--Feb 29, 2024
FIDELITY COVINGTON TRUST0.00%10,098--Jan 31, 2024
Federated Hermes Global Allocation Fund0.00%5,339--Feb 29, 2024
SunAmerica Specialty Series0.00%204--Apr 30, 2021
MASTER INVESTMENT PORTFOLIO0.00%34,854--Mar 31, 2024
Global X Funds0.00%16,785--Jan 31, 2024
MUTUAL FUND SERIES TRUST0.00%1,081,868--Mar 31, 2024
RUSSELL INVESTMENT CO0.00%76,247--Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%625--Mar 31, 2024
NORTHERN FUNDS0.00%31,633--Mar 28, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%11,700--Mar 31, 2024
SEASONS SERIES TRUST0.00%4,300--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%2,087--Mar 31, 2024
EQ ADVISORS TRUST0.00%174,113--Mar 31, 2024
RYDEX SERIES FUNDS0.00%569--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%471,527--Mar 31, 2024
ProFunds0.00%1,275--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%2,452--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%4,276--Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%204,933--Feb 29, 2024
PGIM ETF TRUST0.00%6,446--Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%54,609--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%314--Dec 31, 2023
VALIC Co I0.00%22,101--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%73,727--Mar 31, 2024
Dimensional ETF Trust0.00%29,5902,3778.73%Jan 31, 2024
AMERICAN CENTURY ETF TRUST0.00%7,1897,189-Feb 29, 2024
Guggenheim Active Allocation Fund0.00%355--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%7,784--Mar 31, 2024
ALLSPRING MASTER TRUST0.00%3,473--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%6,553--Jan 31, 2024
RYDEX VARIABLE TRUST0.00%57--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%2,900--Mar 31, 2023
TIAA-CREF FUNDS0.00%131,407--Mar 31, 2024
iSHARES TRUST0.00%700,136--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%9,749--Jan 31, 2024
PROSHARES TRUST0.00%9,885--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%2,460--Feb 29, 2024
GOLDMAN SACHS TRUST0.00%85,307--Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%49,700--Mar 31, 2024
ETF Series Solutions0.00%384--Jan 31, 2024
Legg Mason Global Asset Management Trust0.00%140,000--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%17,686--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%16,0775,90057.97%Jan 31, 2024
PENN SERIES FUNDS INC0.00%400--Mar 28, 2024
VANGUARD WELLINGTON FUND0.00%5,000--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%4,000--Mar 31, 2024
PACIFIC SELECT FUND0.00%32,702--Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%2,388--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%1,713--Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%5,218--Dec 31, 2023
Bridge Builder Trust0.00%22,369--Mar 31, 2024
John Hancock Funds II0.00%50,944--Feb 29, 2024
iShares U.S. ETF Trust0.00%353--Jan 31, 2024
NORTHERN FUNDS0.00%372--Mar 28, 2024
PROSHARES TRUST0.00%634--Feb 29, 2024
BLACKROCK FUNDS0.00%13,292--Mar 28, 2024
WisdomTree Trust0.00%2,845--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%2,770--Mar 31, 2024
BlackRock Variable Series Funds, Inc.0.00%5,787--Mar 31, 2024
Legg Mason Global Asset Management Trust0.00%9,333--Jan 31, 2024
Advisors' Inner Circle Fund III0.00%120--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%378--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%3,610--Feb 29, 2024
Invesco Exchange-Traded Fund Trust II0.00%142--Jan 31, 2024
AQR Funds0.00%106,954--Mar 31, 2024

Solid Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price New Horizons Fund, Inc.", owning 1.97M shares, compromising 0.39% of its total assets.

Solid Biosciences Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 241-
31 Mar, 241-
31 Dec, 231-
30 Sep, 231-50.00%
30 Jun, 232-
31 Mar, 232-
31 Dec, 222-96.43%
30 Sep, 2256-12.50%
30 Jun, 2264-16.88%
31 Mar, 2277-6.10%
31 Dec, 2182-11.83%
30 Sep, 2193-5.10%
30 Jun, 2198-17.65%
31 Mar, 2111936.78%
31 Dec, 208742.62%
30 Sep, 2061-11.59%
30 Jun, 2069-9.21%
31 Mar, 2076-5.00%
31 Dec, 19803.90%
30 Sep, 1977-4.94%
30 Jun, 1981-
31 Mar, 19813.85%
31 Dec, 18782.63%
30 Sep, 187618.75%
30 Jun, 186414.29%
31 Mar, 1856-

As of 30 Jun 24, 1 institutions are holding Solid Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24716.67%
31 Mar, 246-
31 Dec, 236-
30 Sep, 236-91.67%
30 Jun, 2372-
31 Mar, 2372-99.33%
31 Dec, 2210,806-99.98%
30 Sep, 2263,576,082-1.01%
30 Jun, 2264,227,589-7.32%
31 Mar, 2269,298,638-8.29%
31 Dec, 2175,561,529-1.79%
30 Sep, 2176,935,179-4.04%
30 Jun, 2180,171,4471.34%
31 Mar, 2179,109,60744.92%
31 Dec, 2054,587,572111.39%
30 Sep, 2025,823,561-3.58%
30 Jun, 2026,782,73736.38%
31 Mar, 2019,638,958-1.25%
31 Dec, 1919,887,558-38.08%
30 Sep, 1932,117,69751.02%
30 Jun, 1921,267,22224.27%
31 Mar, 1917,113,387-29.26%
31 Dec, 1824,190,79630.02%
30 Sep, 1818,605,0837.35%
30 Jun, 1817,331,3998.76%
31 Mar, 1815,935,456-

Solid Biosciences (SLDB) has 7.00 shares outstanding as of 30 Jun 24, up 16.67% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--
30 Sep, 23-20725.00%
30 Jun, 230.00%250000.00%
31 Mar, 230.00%12.14%
31 Dec, 220.06%0.01%
30 Sep, 2221.66%4.52%
30 Jun, 2221.88%3.93%
31 Mar, 2223.61%3.56%
31 Dec, 2125.74%3.75%
30 Sep, 2126.21%3.51%
30 Jun, 2127.31%3.76%
31 Mar, 2126.95%7.79%
31 Dec, 2018.60%24.03%
30 Sep, 208.80%10.57%
30 Jun, 209.12%20.38%
31 Mar, 206.69%14.57%
31 Dec, 196.78%5.66%
30 Sep, 1910.94%20.84%
30 Jun, 197.25%21.31%
31 Mar, 195.83%8.58%
31 Dec, 188.24%20.51%
30 Sep, 186.34%18.18%
30 Jun, 185.90%20.03%
31 Mar, 185.43%-

As of 30 Jun 24, Solid Biosciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 241-
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 231-50.00%
31 Dec, 222-90.48%
30 Sep, 2221-19.23%
30 Jun, 22268.33%
31 Mar, 2224-41.46%
31 Dec, 214120.59%
30 Sep, 2134-33.33%
30 Jun, 2151-31.08%
31 Mar, 217425.42%
31 Dec, 2059156.52%
30 Sep, 2023-30.30%
30 Jun, 2033-8.33%
31 Mar, 2036-21.74%
31 Dec, 1946-
30 Sep, 1946-
30 Jun, 1946-4.17%
31 Mar, 1948-2.04%
31 Dec, 1849-5.77%
30 Sep, 185223.81%
30 Jun, 1842-25.00%
31 Mar, 1856-

1 institutional shareholders have increased their position in SLDB stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--
31 Mar, 23--
31 Dec, 22--100.00%
30 Sep, 2217-22.73%
30 Jun, 2222-35.29%
31 Mar, 223470.00%
31 Dec, 2120-37.50%
30 Sep, 213252.38%
30 Jun, 2121-
31 Mar, 212190.91%
31 Dec, 2011-56.00%
30 Sep, 202519.05%
30 Jun, 2021-4.55%
31 Mar, 202257.14%
31 Dec, 191416.67%
30 Sep, 1912-7.69%
30 Jun, 1913-13.33%
31 Mar, 1915-6.25%
31 Dec, 181633.33%
30 Sep, 1812-7.69%
30 Jun, 1813-
31 Mar, 18--

- institutional shareholders have reduced their position in SLDB stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 241-716.67%--1---
31 Mar, 241-6-------
31 Dec, 231-6-------
30 Sep, 231-50.00%6-91.67%-20725.00%----
30 Jun, 232-72-0.00%250000.00%--100.00%--
31 Mar, 232-72-99.33%0.00%12.14%1-50.00%--
31 Dec, 222-96.43%10,806-99.98%0.06%0.01%2-90.48%--100.00%
30 Sep, 2256-12.50%63,576,082-1.01%21.66%4.52%21-19.23%17-22.73%
30 Jun, 2264-16.88%64,227,589-7.32%21.88%3.93%268.33%22-35.29%
31 Mar, 2277-6.10%69,298,638-8.29%23.61%3.56%24-41.46%3470.00%
31 Dec, 2182-11.83%75,561,529-1.79%25.74%3.75%4120.59%20-37.50%
30 Sep, 2193-5.10%76,935,179-4.04%26.21%3.51%34-33.33%3252.38%
30 Jun, 2198-17.65%80,171,4471.34%27.31%3.76%51-31.08%21-
31 Mar, 2111936.78%79,109,60744.92%26.95%7.79%7425.42%2190.91%
31 Dec, 208742.62%54,587,572111.39%18.60%24.03%59156.52%11-56.00%
30 Sep, 2061-11.59%25,823,561-3.58%8.80%10.57%23-30.30%2519.05%
30 Jun, 2069-9.21%26,782,73736.38%9.12%20.38%33-8.33%21-4.55%
31 Mar, 2076-5.00%19,638,958-1.25%6.69%14.57%36-21.74%2257.14%
31 Dec, 19803.90%19,887,558-38.08%6.78%5.66%46-1416.67%
30 Sep, 1977-4.94%32,117,69751.02%10.94%20.84%46-12-7.69%
30 Jun, 1981-21,267,22224.27%7.25%21.31%46-4.17%13-13.33%
31 Mar, 19813.85%17,113,387-29.26%5.83%8.58%48-2.04%15-6.25%
31 Dec, 18782.63%24,190,79630.02%8.24%20.51%49-5.77%1633.33%
30 Sep, 187618.75%18,605,0837.35%6.34%18.18%5223.81%12-7.69%
30 Jun, 186414.29%17,331,3998.76%5.90%20.03%42-25.00%13-
31 Mar, 1856-15,935,456-5.43%-56---

Solid Biosciences Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 11, 2024Kahn Claredirector-P-PurchaseBuy1,100$7.67$8.44K1,100
May 06, 2024Ganot Ilandirector-S-SaleSell462$10.33$4.77K9,507

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 11, 2024Kahn Claredirector-P-PurchaseBuy1,100$7.67$8.44K1,100

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 05, 2024SMITH IAN Fdirector-M-ExemptSell3,255--6,510
May 06, 2024Ganot Ilandirector-S-SaleSell462$10.33$4.77K9,507
May 06, 2024Ganot Ilandirector-M-ExemptSell1,553---
Apr 05, 2024SMITH IAN Fdirector-M-ExemptSell3,256--9,765

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 05, 2024SMITH IAN Fdirector-M-ExemptBuy3,255--106,462
Jul 05, 2024SMITH IAN Fdirector-M-ExemptSell3,255--6,510
Jun 13, 2024Keresty Georgiadirector-A-AwardBuy34,400$7.51$258.34K34,400
Jun 13, 2024SMITH IAN Fdirector-A-AwardBuy34,400$7.51$258.34K34,400
Jun 13, 2024Sullivan Lynne Mariedirector-A-AwardBuy34,400$7.51$258.34K34,400
Jun 13, 2024Freed Martin Idirector-A-AwardBuy34,400$7.51$258.34K34,400
Jun 13, 2024Nagendran Sukumardirector-A-AwardBuy34,400$7.51$258.34K34,400
Jun 13, 2024Kahn Claredirector-A-AwardBuy34,400$7.51$258.34K34,400
Jun 13, 2024Ganot Ilandirector-A-AwardBuy34,400$7.51$258.34K34,400
Jun 11, 2024Kahn Claredirector-P-PurchaseBuy1,100$7.67$8.44K1,100
May 06, 2024Ganot Ilandirector-M-ExemptBuy1,553--9,969
May 06, 2024Ganot Ilandirector-S-SaleSell462$10.33$4.77K9,507
May 06, 2024Ganot Ilandirector-M-ExemptSell1,553---
Apr 05, 2024SMITH IAN Fdirector-M-ExemptBuy3,256--103,207
Apr 05, 2024SMITH IAN Fdirector-M-ExemptSell3,256--9,765
Feb 16, 2024Hanrahan Jessieofficer Chief Regulatory OfficerA-AwardBuy65,000$7.85$510.25K65,000
Feb 16, 2024Hanrahan Jessieofficer Chief Regulatory OfficerA-AwardBuy32,500--32,500
Feb 16, 2024Cumbo Alexanderdirector, officer President and CEOA-AwardBuy240,250$7.85$1.89M240,250
Feb 16, 2024Cumbo Alexanderdirector, officer President and CEOA-AwardBuy120,125--120,125
Feb 16, 2024Brooks Gabrielofficer Chief Medical OfficerA-AwardBuy87,500$7.85$686.88K87,500

The last insider sell of Solid Biosciences's stock was made by SMITH IAN F on Jul 05 2024, selling 3,255 shares at - per share (valued at -). The last insider buy of SLDB was made by Kahn Clare on Jun 11 2024, buying 1,100 shares at $7.67 per share (worth $8.44K).

Solid Biosciences Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202411100.00%
Q2 2024103333.33%
Q1 2024268325.00%
Q4 202391275.00%
Q3 202322100.00%
Q2 2023144350.00%
Q1 2023138162.50%
Q4 20223513500.00%
Q3 202211100.00%
Q2 20222012000.00%
Q1 2022144350.00%
Q2 202110--
Q1 20211613123.08%
Q4 202061600.00%
Q3 202071258.33%
Q2 20201811800.00%
Q1 2020182900.00%
Q3 20199--
Q2 2019102500.00%
Q1 201991181.82%

1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Solid Biosciences's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 202411100.00%
Q1 20242366.67%
Q4 2023-5-
Q3 2023---
Q2 2023-1-
Q1 2023-3-
Q4 2022---
Q3 2022---
Q2 2022---
Q1 2022-4-
Q2 2021---
Q1 20212922.22%
Q4 2020---
Q3 2020-6-
Q2 2020---
Q1 2020---
Q3 20191--
Q2 2019-1-
Q1 2019-8-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Solid Biosciences's stocks.

Solid Biosciences Peer Ownership

TickerCompany
PMVPPMV Pharmaceuticals, Inc.
CGEMCullinan Oncology, Inc.
RVMDRevolution Medicines, Inc. Warrant
LRMRLarimar Therapeutics, Inc.
MLYSMineralys Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
STOKStoke Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
ALECAlector, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
BDTXBlack Diamond Therapeutics, Inc.
BCELAtreca, Inc.
CABACabaletta Bio, Inc.
PASGPassage Bio, Inc.
CCCCC4 Therapeutics, Inc.
GLUEMonte Rosa Therapeutics, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
MOLNMolecular Partners AG

SLDB Ownership FAQ

Solid Biosciences is owned by institutional shareholders (0%), insiders (0.85%), and public (0%). The largest institutional shareholder of Solid Biosciences is PARALLEL ADVISORS, LLC (0% of total shares) and the top mutual fund owner is T. Rowe Price New Horizons Fund, Inc. (0.39% of total shares).

Solid Biosciences's major institutional shareholders are PARALLEL ADVISORS, LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Jun 2024, there are 1 institutional shareholders of Solid Biosciences.

PARALLEL ADVISORS, LLC owns 7 shares of Solid Biosciences, representing 0% of the company's total shares outstanding, valued at $40 (as of Jun 2024).